Form 4 Filing for Beta Bionics, Inc. - Officer/Director Transaction

Maria Palasis, a director at Beta Bionics, Inc. (BBNX), acquired 16,965 shares of common stock on May 21, 2026, through a restricted stock unit award granted under the company's 2025 Equity Incentive Plan. The acquisition was made at a price of $0.0 per share. Following this transaction, Palasis now owns a total of 29,397 shares of common stock. The filing, designated as Form 4, was signed by Stephen Feider as Attorney-in-Fact on May 26, 2026. This transaction is categorized as an equity incentive award and does not involve any cash payment.